Zobrazeno 1 - 10
of 10
pro vyhledávání: '"C van Beurden-Tan"'
Publikováno v:
Value in Health. 25:S372-S373
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0955fe97a6aedad29dc9b8427d1fec7f
https://doi.org/10.1016/j.jval.2022.04.450
https://doi.org/10.1016/j.jval.2022.04.450
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Nicole M. A. Blijlevens, Pieter Sonneveld, M Franken, S. de Groot, Sonja Zweegman, C. van Beurden-Tan, Hedwig M. Blommestein, Uyl-de Groot Ca
Publikováno v:
Value in Health, 21, S10-S11. Elsevier Limited
Blommestein, H, Groot CA, U, Sonneveld, P, de Groot, S, Zweegman, S, Franken, M G, van Beurden-Tan, C & Blijlevens, N 2018, ' MO1-COMBINING INTERNALLY VALID TRIAL EVIDENCE WITH GENERALIZABLE REAL-WORLD DATA: INSIGHTS INTO EFFECTS, COSTS, AND COST-EFFECTIVENESS OF NOVEL TREATMENT SEQUENCES IN PATIENTS WITH MULTIPLE MYELOMA ', Value in Health, vol. 21, pp. S10-S11 . https://doi.org/10.1016/j.jval.2018.09.061
Blommestein, H, Groot CA, U, Sonneveld, P, de Groot, S, Zweegman, S, Franken, M G, van Beurden-Tan, C & Blijlevens, N 2018, ' MO1-COMBINING INTERNALLY VALID TRIAL EVIDENCE WITH GENERALIZABLE REAL-WORLD DATA: INSIGHTS INTO EFFECTS, COSTS, AND COST-EFFECTIVENESS OF NOVEL TREATMENT SEQUENCES IN PATIENTS WITH MULTIPLE MYELOMA ', Value in Health, vol. 21, pp. S10-S11 . https://doi.org/10.1016/j.jval.2018.09.061
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed2d7e610c9b9a71c88dd2669fa57e95
https://doi.org/10.1016/j.jval.2018.09.061
https://doi.org/10.1016/j.jval.2018.09.061
Publikováno v:
Value in Health. 22:S480
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::695aa138f05f33b949a65a1bebf48e57
https://doi.org/10.1016/j.jval.2019.09.421
https://doi.org/10.1016/j.jval.2019.09.421
Publikováno v:
Value in Health. 17(7)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f857b2c52fe2e387f6eccaa95c271d2
Autor:
Herman Einsele, Johan Liwing, Hareth Nahi, C. van Beurden-Tan, M. Van Agthoven, B. Heeg, Antonio Palumbo, P. G. Richardson, Johan Aschan, F. Logman, Torben Plesner, U. H. Mellqvist, MJ Treur, Mirjam Barendse, Pieter Sonneveld
Publikováno v:
Value in Health. 17:A617-A618
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15f512d77ae1ef4f3a1f39767477cb07
https://doi.org/10.1016/j.jval.2014.08.2182
https://doi.org/10.1016/j.jval.2014.08.2182
Publikováno v:
Value in Health. 16:A576-A577
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::436caf65ed25b66ead133646ccfd44ab
https://doi.org/10.1016/j.jval.2013.08.1565
https://doi.org/10.1016/j.jval.2013.08.1565
Autor:
J. Diels, D. Wirth, Sophia E. Marsh, J.J. Lahuerta, J F San Miguel, Laura Rosiñol, S. Gaugris, C. van Beurden-Tan, M. Spencer, M. Treur, O. Chirita, J. Bladé
Publikováno v:
Value in Health. 16:A409-A410
Van Beurden-Tan C1, Rosinol L2, Diels J3, Wirth D4, Chirita O5, Lahuerta JJ6, Gaugris S5, Marsh S5, San Miguel J7, Spencer M5, Treur M1 and Blade J2 1Pharmerit International, Rotterdam, The Netherlands, 2Hospital Clinic de Barcelona, Barcelona, Spain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c00af54f72374acb64597e6defe55f3f
https://doi.org/10.1016/j.jval.2013.08.498
https://doi.org/10.1016/j.jval.2013.08.498
Autor:
Bouwmeester W; Pharmerit International, Rotterdam, The Netherlands., van Beurden-Tan C; Pharmerit International, Rotterdam, The Netherlands., Bennison C; Pharmerit Ltd, York, UK., Heeg B; Pharmerit International, Rotterdam, The Netherlands.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2014 Nov; Vol. 17 (7), pp. A566. Date of Electronic Publication: 2014 Oct 26.
Autor:
Heeg B; Pharmerit International, Rotterdam, The Netherlands., Van Agthoven M; Janssen-Cilag BV, Tilburg, The Netherlands., van Beurden-Tan C; Erasmus University Medical Center, Rotterdam, The Netherlands., Liwing J; Janssen-Cilag AB, Sollentuna, Sweden., Mellqvist UH; Department of Hematology, Gothenburg, Sweden., Plesner T; Vejle Hospital, Vejle, Denmark., Logman F; Eastbridge Pharma BV, Utrecht, The Netherlands., Aschan J; Janssen-Cilag AB, Sollentuna, Sweden., Einsele H; Medizinische Klinik II, Würzburg, Germany., Treur M; Pharmerit International, Rotterdam, The Netherlands., Barendse M; Janssen-Cilag AB, Sollentuna, Sweden., Richardson PG; Dana-Farber Cancer Institute, Boston, MA, USA., Palumbo A; University of Torino, Torino, Italy., Nahi H; Karolinska University Hospital, Solna, Sweden., Sonneveld P; Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2014 Nov; Vol. 17 (7), pp. A617-8. Date of Electronic Publication: 2014 Oct 26.